| 摘要: |
| 目的 介绍近年来应用于2型糖尿病的新型药物GLP-1类似物、DPP-IV阻断剂及作用于ECS的药物。方法 归纳总结国外相关文献，介绍其作用机制、临床实践、不良反应、权威使用指南。结果与结论 此类药物具有一定应用前景，但仍存在较多问题，需要进一步探讨和研究。 |
| 关键词: 2型糖尿病 GLP-1类似物 DPP-IV阻断剂 作用于ECS药物 |
| DOI： |
| 分类号: |
| 基金项目: |
|
| Latest Progress of Drugs Used in Type-2 Diabetes Mellitus Treatment |
|
SHEN Jianmin
|
|
Medical Department of Dezhou University, Dezhou 253023, China
|
| Abstract: |
| OBJECTIVE To introduce the newest antidiabetic drugs, GLP-1 analogues, DPP-IV inhibitors and drugs which act on ESC. METHODS The latest research reports were reviewed, and those drugs’ action mechanism, clinical practice, side effects and guideline that expressed by authoritative department were included. RESULTS AND CONCLUSION Those new antidiabetic drugs have hopeful future but there are many problems that need to study and resolve in the future. |
| Key words: type-2 diabetes GLP-1 analogues DPP-IV inhibitors drugs act on ECS |
